Literature DB >> 22964168

Treatment decisions for metastatic castration-resistant prostate cancer progressing after docetaxel chemotherapy: the role of cabazitaxel in the continuum of care.

Axel Heidenreich, David Pfister.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22964168     DOI: 10.1016/j.eururo.2012.08.048

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

1.  [Chemotherapy of prostate cancer].

Authors:  C-H Ohlmann
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.